Literature DB >> 20235066

Hip arthroplasty in morbidly obese patients - intra-operative and short term outcomes.

Damien Bennett1, Dessie Gibson, Seamus O'Brien, David E Beverland.   

Abstract

Morbidly obese patients experienced significantly longer operation times (66 minutes) and longer wounds (14.2 cm) compared to normal THA patients (58 minutes and 12.1 cm respectively). However, intra-operative anaesthetic time and length of hospital stay were not significantly different between the MO and normal patients. Improvements in patient outcomes following THA were not significantly different between the MO and normal patients at one year follow-up. Improvements in sagittal range of motion and external rotation were significantly less for MO patients. Intraoperative complication rates were 0% for the MO and 3.5% for the normal patients. Postoperative complication rates were 3.5% for the MO and 0% for the normal patients. THA operation times for MO patients were on average only 8 minutes longer and should not represent a barrier to surgery. Hospital length of stay was not longer for MO patients suggesting they do not represent a greater burden on healthcare resources during THA.

Entities:  

Mesh:

Year:  2010        PMID: 20235066     DOI: 10.1177/112070001002000111

Source DB:  PubMed          Journal:  Hip Int        ISSN: 1120-7000            Impact factor:   2.135


  3 in total

1.  Does warming up improve surgical outcome in total hip arthroplasty?

Authors:  Asim M Makhdom; AbdulAziz Almaawi; Dylan Tanzer; Michael Tanzer
Journal:  Eur J Orthop Surg Traumatol       Date:  2015-08-20

2.  Hip Arthroplasty in Obese Patients: Rising Prevalence-Standard Procedures?

Authors:  Michael Skutek; Nils Wirries; Gabriela von Lewinski
Journal:  Orthop Rev (Pavia)       Date:  2016-06-27

3.  Effect of morbid obesity on patient-reported outcomes in total joint arthroplasty: a minimum of 1-year follow-up.

Authors:  Mohamad J Halawi; Christian Gronbeck; Lawrence Savoy; Mark P Cote
Journal:  Arthroplast Today       Date:  2019-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.